NCT02973958View on ClinicalTrials.gov

Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

June 28, 2018

Study Completion Date

June 28, 2018

Conditions
Pain, PostoperativePhimosisParaphimosisBalanitis
Interventions
DRUG

Bupivacaine

See active comparator description

DRUG

Sevoflurane

See active comparator description

DRUG

Acetaminophen

See active comparator description

DRUG

Ibuprofen

See active comparator description

DRUG

Ketorolac

See experimental arm description

Trial Locations (1)

T3B 6A8

Alberta Children's Hospital, Calgary

All Listed Sponsors
lead

Alberta Children's Hospital

OTHER

NCT02973958 - Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision | Biotech Hunter | Biotech Hunter